Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q0FW
|
|||
| Former ID |
DIB020474
|
|||
| Drug Name |
N1-methylnicotinamide
|
|||
| Synonyms |
Trigonellinamide; 1-methylnicotinamide; N(1)-Methylnicotinamide; N1-Methylnicotinamide; 3-(Aminocarbonyl)-1-methylpyridinium; 1-Methyl nicotinamide; 3-carbamoyl-1-methylpyridinium; 3106-60-3; Pyridinium, 3-carbamoyl-1-methyl-; UNII-UM47085BXC; N(sup 1)-Methylnicotinamide; 3-carbamoyl-1-methylpyridin-1-ium; BRN 3540351; 1-methylpyridine-3-carboxamide; UM47085BXC; CHEBI:16797; 1-methylpyridin-1-ium-3-carboxamide; CHEMBL1209652; Trigonellamide; Pyridinium, 3-(aminocarbonyl)-1-methyl-; 1-methyl-3-carbamoylpyridinium; 8GC; I-methyl n
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hyperlipidemia [ICD-11: 5C80.Z] | Phase 2/3 | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C7H9N2O+
|
|||
| Canonical SMILES |
C[N+]1=CC=CC(=C1)C(=O)N
|
|||
| InChI |
1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1
|
|||
| InChIKey |
LDHMAVIPBRSVRG-UHFFFAOYSA-O
|
|||
| CAS Number |
CAS 3106-60-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
2394, 5841, 954035, 5155051, 6555085, 8143645, 8150650, 24438826, 33903490, 48499499, 50033274, 50244387, 56365883, 57320223, 88524034, 103129273, 103268845, 104294886, 107212253, 111677778, 117563530, 124578372, 125672344, 126523494, 127374407, 128423050, 128472654, 135022414, 137136540, 142268689, 142454104, 143405732, 162889726, 163365524, 164817027, 169196253, 178101374, 179293117, 198975697, 223460099, 226500804, 241067449, 243882470, 246430415
|
|||
| ChEBI ID |
CHEBI:16797
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00519714) A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.